177 related articles for article (PubMed ID: 13678797)
1. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides.
Holm R; Porter CJ; Edwards GA; Müllertz A; Kristensen HG; Charman WN
Eur J Pharm Sci; 2003 Sep; 20(1):91-7. PubMed ID: 13678797
[TBL] [Abstract][Full Text] [Related]
2. Structured triglyceride vehicles for oral delivery of halofantrine: examination of intestinal lymphatic transport and bioavailability in conscious rats.
Holm R; Porter CJ; Müllertz A; Kristensen HG; Charman WN
Pharm Res; 2002 Sep; 19(9):1354-61. PubMed ID: 12403073
[TBL] [Abstract][Full Text] [Related]
3. Comparison of total oral bioavailability and the lymphatic transport of halofantrine from three different unsaturated triglycerides in lymph-cannulated conscious rats.
Holm R; Müllertz A; Christensen E; Høy CE; Kristensen HG
Eur J Pharm Sci; 2001 Dec; 14(4):331-7. PubMed ID: 11684408
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the lymphatic transport of halofantrine administered in disperse systems containing three different unsaturated fatty acids.
Holm R; Müllertz A; Pedersen GP; Kristensen HG
Pharm Res; 2001 Sep; 18(9):1299-304. PubMed ID: 11683243
[TBL] [Abstract][Full Text] [Related]
5. Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs.
Khoo SM; Shackleford DM; Porter CJ; Edwards GA; Charman WN
Pharm Res; 2003 Sep; 20(9):1460-5. PubMed ID: 14567642
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion.
Porter CJ; Charman SA; Charman WN
J Pharm Sci; 1996 Apr; 85(4):351-6. PubMed ID: 8901067
[TBL] [Abstract][Full Text] [Related]
7. Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems.
Wu H; Zhou A; Lu C; Wang L
Eur J Pharm Sci; 2011 Mar; 42(4):348-53. PubMed ID: 21216284
[TBL] [Abstract][Full Text] [Related]
8. A mouse model to evaluate the impact of species, sex, and lipid load on lymphatic drug transport.
Trevaskis NL; Caliph SM; Nguyen G; Tso P; Charman WN; Porter CJ
Pharm Res; 2013 Dec; 30(12):3254-70. PubMed ID: 23430484
[TBL] [Abstract][Full Text] [Related]
9. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats.
Caliph SM; Charman WN; Porter CJ
J Pharm Sci; 2000 Aug; 89(8):1073-84. PubMed ID: 10906731
[TBL] [Abstract][Full Text] [Related]
10. Influence of the type of surfactant and the degree of dispersion on the lymphatic transport of halofantrine in conscious rats.
Karpf DM; Holm R; Kristensen HG; Müllertz A
Pharm Res; 2004 Aug; 21(8):1413-8. PubMed ID: 15359576
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
Grove M; Müllertz A; Nielsen JL; Pedersen GP
Eur J Pharm Sci; 2006 Jun; 28(3):233-42. PubMed ID: 16650738
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation.
Porter CJ; Kaukonen AM; Boyd BJ; Edwards GA; Charman WN
Pharm Res; 2004 Aug; 21(8):1405-12. PubMed ID: 15359575
[TBL] [Abstract][Full Text] [Related]
13. A conscious dog model for assessing the absorption, enterocyte-based metabolism, and intestinal lymphatic transport of halofantrine.
Khoo SM; Edwards GA; Porter CJ; Charman WN
J Pharm Sci; 2001 Oct; 90(10):1599-607. PubMed ID: 11745718
[TBL] [Abstract][Full Text] [Related]
14. Oral absorption and lymphatic transport of baicalein following drug-phospholipid complex incorporation in self-microemulsifying drug delivery systems.
Liao H; Gao Y; Lian C; Zhang Y; Wang B; Yang Y; Ye J; Feng Y; Liu Y
Int J Nanomedicine; 2019; 14():7291-7306. PubMed ID: 31564878
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS).
Thomas N; Holm R; Müllertz A; Rades T
J Control Release; 2012 May; 160(1):25-32. PubMed ID: 22405903
[TBL] [Abstract][Full Text] [Related]
16. Self microemulsifying drug delivery system of lurasidone hydrochloride for enhanced oral bioavailability by lymphatic targeting: In vitro, Caco-2 cell line and in vivo evaluation.
Patel MH; Sawant KK
Eur J Pharm Sci; 2019 Oct; 138():105027. PubMed ID: 31377133
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic transport of halofantrine in the conscious rat when administered as either the free base or the hydrochloride salt: effect of lipid class and lipid vehicle dispersion.
Porter CJ; Charman SA; Humberstone AJ; Charman WN
J Pharm Sci; 1996 Apr; 85(4):357-61. PubMed ID: 8901068
[TBL] [Abstract][Full Text] [Related]
18. Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead.
Dokania S; Joshi AK
Drug Deliv; 2015; 22(6):675-90. PubMed ID: 24670091
[TBL] [Abstract][Full Text] [Related]
19. Development of Self-Microemulsifying Drug Delivery System to Improve Nisoldipine Bioavailability: Cell Line and In Vivo Evaluations : Development of Self-Microemulsifying Drug Delivery System.
Mundada VP; Patel MH; Mundada PK; Sawant KK
AAPS PharmSciTech; 2021 Oct; 22(8):256. PubMed ID: 34676456
[TBL] [Abstract][Full Text] [Related]
20. Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80.
Lind ML; Jacobsen J; Holm R; Müllertz A
Eur J Pharm Sci; 2008 Oct; 35(3):211-8. PubMed ID: 18675904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]